These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3391636)

  • 1. The second component of human complement: detection of two hemolytic forms in plasma by pH variation.
    Schultz DR; Loos M
    Immunobiology; 1988 Mar; 176(4-5):374-93. PubMed ID: 3391636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of the fourth, second and fifth components of mouse complement.
    Fukuoka Y; Seino J; Okuda T; Tachibana T
    Immunology; 1984 Mar; 51(3):493-501. PubMed ID: 6698577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and biochemical properties of the early classical complement system of mice.
    Goldman MB; Bangalore S; Goldman JN
    J Immunol; 1978 Jan; 120(1):216-24. PubMed ID: 627718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the anticomplementary activity in sera of three African patients with parasitic and bacteriological infections.
    Loos M; Dierich MP
    Infect Immun; 1980 Jan; 27(1):1-5. PubMed ID: 7358423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
    Smith MA; Kerr MA
    Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of functionally or highly pure C2 from human plasma with Sepharose and a lectin of Euonymus europeus.
    Schultz DR; Arnold PI
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():59-66. PubMed ID: 6587744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The second component of human complement: use of glycosidases and glucosylation to distinguish the two forms.
    Schultz DR; Loos M
    Immunobiology; 1988 Mar; 176(4-5):394-409. PubMed ID: 3391637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of a structurally abnormal C2 complement protein by macrophages from C2-deficient guinea pigs.
    Goldberger G; Cole FS; Einstein LP; Auerbach HS; Bitter-Suermann D; Colten HR
    J Immunol; 1982 Nov; 129(5):2061-5. PubMed ID: 6922142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
    Knutzen Steuer KL; Sloan LB; Oglesby TJ; Farries TC; Nickells MW; Densen P; Harley JB; Atkinson JP
    J Immunol; 1989 Oct; 143(7):2256-61. PubMed ID: 2506280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus.
    Ueda A; Kusaba T; Yanase T
    Clin Exp Immunol; 1983 Jul; 53(1):217-24. PubMed ID: 6409476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human C4. I. Purification of hemolytically active C4 from small volumes of normal serum.
    Spinella DG; Shah DD; Hale PD; Levine RP
    Complement; 1984; 1(4):187-93. PubMed ID: 6399882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HIV-1 protease cleavage site in human C1-inhibitor.
    Gerencer M; Burek V
    Virus Res; 2004 Sep; 105(1):97-100. PubMed ID: 15325085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new haemolytic assay for the second component of complement (C2) in human serum.
    Naish PF; Barratt J; Collins C
    Clin Exp Immunol; 1976 Sep; 25(3):487-9. PubMed ID: 963910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig.
    Bitter-Suermann D; Hoffmann T; Burger R; Hadding U
    J Immunol; 1981 Aug; 127(2):608-12. PubMed ID: 7252150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
    Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
    Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.